IMMUNE PHARMACEUTICALS INC (IMNP) has 18 open-market insider trades by 9 insiders since 2014. The most active filer is Daniel Kazado, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Daniel Kazado | Dir | — | 6 | $856K | 2017-01-04 |
| Monica E. Luchi | CMOVP | — | 1 | $700K | 2016-08-04 |
| Daniel Gedeon Teper | CEO | — | 4 | $466K | 2016-10-06 |
| Rene Pierre Azria | Dir | — | 1 | $74K | 2015-09-14 |
| David Sidransky | Dir | — | 1 | $26K | 2015-01-08 |
| Gad Berdugo | Dir | — | 1 | $20K | 2014-11-26 |
| Ana Stancic | Dir | — | 1 | $20K | 2014-11-26 |
| Anthony S. Fiorino | Chief Medical Officer and COO | — | 2 | $19K | 2018-05-22 |
| Cameron Durrant | Dir | — | 1 | $10K | 2014-11-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Anthony S. Fiorino | Chief Medical Officer and COO | Buy | $6K | 2018-05-22 |
| Anthony S. Fiorino | Chief Medical Officer and COO | Buy | $13K | 2018-05-17 |
| Daniel Kazado | Director | Buy | $15K | 2017-01-04 |
| Daniel Kazado | Director | Buy | $31K | 2016-12-16 |
| Daniel Kazado | Director | Buy | $600K | 2016-08-04 |
| Monica E. Luchi | CMO & VP | Buy | $700K |
Companies that share insiders with IMNP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2016-08-04 |
| Daniel Gedeon Teper | CEO & 10% | Buy | $356K | 2016-08-04 |
| Daniel Gedeon Teper | CEO & 10% | Buy | $25K | 2016-01-26 |
| Daniel Gedeon Teper | CEO & 10% | Buy | $25K | 2016-01-19 |
| Daniel Gedeon Teper | CEO & 10% | Buy | $24K | 2016-01-12 |
| Daniel Gedeon Teper | CEO | Buy | $50K | 2016-01-05 |
| Daniel Kazado | Director | Buy | $117K | 2015-12-07 |
| Daniel Gedeon Teper | CEO & 10% | Buy | $50K | 2015-12-07 |
| Daniel Gedeon Teper | CEO & 10% | Buy | $25K | 2015-10-26 |
| Daniel Gedeon Teper | CEO | Buy | $25K | 2015-10-19 |